🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
Last 30 Days
›
Healthcare Sector
Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.2:1
Daily Buy & Sell Volume
Log Scale
Transactions
(1655)
All (1655)
Buys (244)
Sells (1411)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
BillionToOne, Inc.
(BLLN)
Tsao David
— Director
Oct 5, 2026
Sale
Shares
2,921
Price
$109.00
Total Value
$318.40K
Shares Held After
11,020
% of Holdings
21.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BillionToOne, Inc.
(BLLN)
Tsao David
— Director
Oct 5, 2026
Sale
Shares
4,284
Price
$108.39
Total Value
$464.36K
Shares Held After
13,941
% of Holdings
23.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BillionToOne, Inc.
(BLLN)
Tsao David
— Director
Oct 5, 2026
Sale
Shares
1,909
Price
$107.19
Total Value
$204.64K
Shares Held After
18,225
% of Holdings
9.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BillionToOne, Inc.
(BLLN)
Tsao David
— Director
Oct 5, 2026
Sale
Shares
866
Price
$105.90
Total Value
$91.71K
Shares Held After
20,134
% of Holdings
4.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
GRAIL, Inc.
(GRAL)
Partridge Andrew John
— Chief Growth Officer
Oct 5, 2026
Sale
Shares
7,873
Price
$146.39
Total Value
$1.15M
Shares Held After
155,865
% of Holdings
4.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
GRAIL, Inc.
(GRAL)
Freidin Aaron
— Chief Financial Officer
Oct 5, 2026
Sale
Shares
23,619
Price
$146.39
Total Value
$3.46M
Shares Held After
225,364
% of Holdings
9.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
4D Molecular Therapeutics, Inc.
(FDMT)
Kirn David
— Director
Oct 5, 2026
Sale
Shares
272
Price
$13.61
Total Value
$3.70K
Shares Held After
709,153
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
4D Molecular Therapeutics, Inc.
(FDMT)
Kirn David
— Director
Oct 5, 2026
Sale
Shares
58,061
Price
$12.92
Total Value
$750.24K
Shares Held After
709,425
% of Holdings
7.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PTC THERAPEUTICS, INC.
(PTCT)
Boulding Mark Elliott
— EXEC. VP AND CLO
Oct 5, 2026
Sale
Shares
1,638
Price
$64.03
Total Value
$104.88K
Shares Held After
105,272
% of Holdings
1.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Ginkgo Bioworks Holdings, Inc.
(DNA)
Coen Steven P.
— Chief Financial Officer
Oct 5, 2026
Sale
Shares
2,403
Price
$15.00
Total Value
$36.05K
Shares Held After
49,448
% of Holdings
4.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Acrivon Therapeutics, Inc.
(ACRV)
Miller Mary
— Chief Legal Officer
Oct 5, 2026
Sale
Shares
294
Price
$1.99
Total Value
$585.06
Shares Held After
81,715
% of Holdings
0.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CASTLE BIOSCIENCES INC
(CSTL)
MAETZOLD DEREK J
— Director
Oct 5, 2026
Sale
Shares
2,718
Price
$35.57
Total Value
$96.67K
Shares Held After
6,832
% of Holdings
28.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CASTLE BIOSCIENCES INC
(CSTL)
MAETZOLD DEREK J
— Director
Oct 5, 2026
Sale
Shares
3,198
Price
$35.57
Total Value
$113.74K
Shares Held After
8,038
% of Holdings
28.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CASTLE BIOSCIENCES INC
(CSTL)
MAETZOLD DEREK J
— Director
Oct 5, 2026
Sale
Shares
8,580
Price
$35.57
Total Value
$305.16K
Shares Held After
21,064
% of Holdings
28.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Twist Bioscience Corp
(TWST)
Leproust Emily M.
— Director
Oct 5, 2026
Sale
Shares
45
Price
$207.46
Total Value
$9.34K
Shares Held After
562,760
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Twist Bioscience Corp
(TWST)
Leproust Emily M.
— Director
Oct 5, 2026
Sale
Shares
146
Price
$206.84
Total Value
$30.20K
Shares Held After
562,805
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Twist Bioscience Corp
(TWST)
Leproust Emily M.
— Director
Oct 5, 2026
Sale
Shares
297
Price
$205.78
Total Value
$61.12K
Shares Held After
562,951
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Twist Bioscience Corp
(TWST)
Leproust Emily M.
— Director
Oct 5, 2026
Sale
Shares
290
Price
$204.80
Total Value
$59.39K
Shares Held After
563,248
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Twist Bioscience Corp
(TWST)
Leproust Emily M.
— Director
Oct 5, 2026
Sale
Shares
432
Price
$203.61
Total Value
$87.96K
Shares Held After
563,538
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Twist Bioscience Corp
(TWST)
Leproust Emily M.
— Director
Oct 5, 2026
Sale
Shares
1,017
Price
$202.32
Total Value
$205.76K
Shares Held After
563,970
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Twist Bioscience Corp
(TWST)
Leproust Emily M.
— Director
Oct 5, 2026
Sale
Shares
481
Price
$201.26
Total Value
$96.80K
Shares Held After
564,987
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Twist Bioscience Corp
(TWST)
Leproust Emily M.
— Director
Oct 5, 2026
Sale
Shares
1,840
Price
$200.44
Total Value
$368.81K
Shares Held After
565,468
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Vaxcyte, Inc.
(PCVX)
Cowan Elvia
— SVP, Finance&CAO
Oct 5, 2026
Sale
Shares
19,000
Price
$86.74
Total Value
$1.65M
Shares Held After
27,860
% of Holdings
40.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Vaxcyte, Inc.
(PCVX)
Wassil Jim
— EVP, Chief Scientific Ofc, COO
Oct 5, 2026
Sale
Shares
18,000
Price
$86.74
Total Value
$1.56M
Shares Held After
145,435
% of Holdings
11.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Liquidia Corp
(LQDA)
Bloch Stephen M
— Director
Oct 5, 2026
Sale
Shares
235,477
Price
$27.13
Total Value
$6.39M
Shares Held After
0
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Amylyx Pharmaceuticals, Inc.
(AMLX)
MILNE GEORGE M JR
— Director
Oct 5, 2026
Sale
Shares
30,000
Price
$27.70
Total Value
$830.90K
Shares Held After
782,881
% of Holdings
3.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SOPHiA GENETICS SA
(SOPH)
Xu Zhenyu
— Chief Scientific Officer
Oct 5, 2026
Sale
Shares
7,394
Price
$8.12
Total Value
$60.07K
Shares Held After
545,493
% of Holdings
1.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SOPHiA GENETICS SA
(SOPH)
Muken Ross
— Director
Oct 5, 2026
Sale
Shares
9,838
Price
$8.13
Total Value
$79.97K
Shares Held After
660,391
% of Holdings
1.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SOPHiA GENETICS SA
(SOPH)
Menu Philippe
— Chief Medical Officer
Oct 5, 2026
Sale
Shares
7,394
Price
$8.13
Total Value
$60.10K
Shares Held After
200,993
% of Holdings
3.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SOPHiA GENETICS SA
(SOPH)
CARDOZA GEORGE
— Chief Financial Officer
Oct 5, 2026
Sale
Shares
1,592
Price
$8.10
Total Value
$12.90K
Shares Held After
306,726
% of Holdings
0.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SOPHiA GENETICS SA
(SOPH)
Camblong Jurgi
— Director
Oct 5, 2026
Sale
Shares
40,172
Price
$8.13
Total Value
$326.53K
Shares Held After
3,395,650
% of Holdings
1.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SOPHiA GENETICS SA
(SOPH)
Verma Abhimanyu
— Chief Technology Officer
Oct 5, 2026
Sale
Shares
5,284
Price
$8.12
Total Value
$42.93K
Shares Held After
166,887
% of Holdings
3.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SOPHiA GENETICS SA
(SOPH)
Puylaert Kevin
— Chief Sales Officer
Oct 5, 2026
Sale
Shares
31
Price
$7.92
Total Value
$245.52
Shares Held After
147,732
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SOPHiA GENETICS SA
(SOPH)
Puylaert Kevin
— Chief Sales Officer
Oct 5, 2026
Sale
Shares
185
Price
$8.06
Total Value
$1.49K
Shares Held After
147,763
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SOPHiA GENETICS SA
(SOPH)
Valente Manuela
— Chief People Officer
Oct 5, 2026
Sale
Shares
4,240
Price
$8.13
Total Value
$34.49K
Shares Held After
206,210
% of Holdings
2.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SOPHiA GENETICS SA
(SOPH)
Van Well Daan
— Chief Legal Officer
Oct 5, 2026
Sale
Shares
6,168
Price
$8.12
Total Value
$50.10K
Shares Held After
332,716
% of Holdings
1.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Medline Inc.
(MDLN)
GIC Private Ltd
— 10% Owner
Oct 5, 2026
Sale
Shares
1,688,690
Price
$35.78
Total Value
$60.42M
Shares Held After
18,542,793
% of Holdings
8.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SI-BONE, Inc.
(SIBN)
Maheshwari Anshul
— Chief Op&Financial Officer
Oct 5, 2026
Sale
Shares
1,731
Price
$19.50
Total Value
$33.75K
Shares Held After
218,235
% of Holdings
0.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ImmunityBio, Inc.
(IBRX)
Simon Barry J.
— Director
Oct 5, 2026
Sale
Shares
25,000
Price
$10.75
Total Value
$268.76K
Shares Held After
2,777,788
% of Holdings
0.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BICYCLE THERAPEUTICS PLC
(BCYC)
Lee Kevin
— Director
Oct 5, 2026
Sale
Shares
1,638
Price
$3.57
Total Value
$5.85K
Shares Held After
595,866
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BICYCLE THERAPEUTICS PLC
(BCYC)
Skynner Michael
— CHIEF SCIENTIFIC OFFICER
Oct 5, 2026
Sale
Shares
503
Price
$3.57
Total Value
$1.80K
Shares Held After
154,726
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BICYCLE THERAPEUTICS PLC
(BCYC)
Perry Jennifer Scott
— Chief Operating Officer
Oct 5, 2026
Sale
Shares
326
Price
$3.78
Total Value
$1.23K
Shares Held After
89,552
% of Holdings
0.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BICYCLE THERAPEUTICS PLC
(BCYC)
Perry Jennifer Scott
— Chief Operating Officer
Oct 5, 2026
Sale
Shares
80
Price
$3.56
Total Value
$284.80
Shares Held After
89,878
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BICYCLE THERAPEUTICS PLC
(BCYC)
Hannay Michael Charles Ferguson
— CHIEF PROD&SUPPLY CHAIN OFF
Oct 5, 2026
Sale
Shares
242
Price
$3.57
Total Value
$863.94
Shares Held After
92,561
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CARLSMED, INC.
(CARL)
Bertolini Jeffrey
— Chief Operating Officer
Oct 5, 2026
Sale
Shares
747
Price
$14.39
Total Value
$10.75K
Shares Held After
22,489
% of Holdings
3.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BioNTech SE
(BNTX)
Sahin Ugur
— Chief Executive Officer
Oct 5, 2026
Sale
Shares
72,000
Price
$97.23
Total Value
$7.00M
Shares Held After
108,209
% of Holdings
40.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
REPLIGEN CORP
(RGEN)
Loeillot Olivier
— Director
Oct 5, 2026
Sale
Shares
4,202
Price
$190.00
Total Value
$798.38K
Shares Held After
45,788
% of Holdings
8.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
REPLIGEN CORP
(RGEN)
Loeillot Olivier
— Director
Oct 5, 2026
Sale
Shares
1,333
Price
$178.75
Total Value
$238.27K
Shares Held After
45,788
% of Holdings
2.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Oct 5, 2026
Sale
Shares
360
Price
$546.63
Total Value
$196.79K
Shares Held After
324,443
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Oct 5, 2026
Sale
Shares
920
Price
$545.69
Total Value
$502.04K
Shares Held After
324,803
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
← Previous
Next →
Showing 101–150 of 1655 transactions (page 3 of 34)
Version: v26.10.6